We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Neuromodulation Platform Alleviates Chronic Pain

By HospiMedica International staff writers
Posted on 26 May 2020
Print article
Image: The Senza Omnia SCS system (Photo courtesy of Nevro)
Image: The Senza Omnia SCS system (Photo courtesy of Nevro)
An innovative spinal cord stimulation system (SCS) treats chronic pain by delivering proprietary high frequency (HF) and other waveforms.

The Nevro (Menlo Park, CA, USA) Omnia system is a new SCS platform that offers a wide array of waveforms across the full SCS frequency spectrum, either separately or paired together with proprietary HF10. The system includes the Omnia programmer, a patient remote control that supports a programming capacity, allowing flexibility beyond the proprietary HF10 algorithm by providing the ability of employing additional waveforms. A third component is a redesigned, slimmer patient charger with an improved interface that is designed to last over ten years, no matter what stimulation profile is used.

An updated and upgradeable implantable pulse generator delivers an ultra-wide range of frequencies, between 2 and 10,000 Hz. In addition, the ability to pair frequencies allows Omnia to pair HF10--the most studied SCS therapy, with over 55,000 patients treated across the world--with other waveforms, including traditional, paresthesia-based stimulation, subthreshold 1 kHz therapy, or burst waveforms. In addition, the system has conditional full body magnetic resonance imaging (MRI) approval, and will be upgradeable to future waveforms and frequencies.

“This next-generation SCS system has been developed in close consultation with customers and is designed to provide a comprehensive solution to manage chronic pain. As conditions in the marketplace allow, we will be introducing Omnia to physicians throughout Europe,” said D. Keith Grossman, Chairman, CEO, and President of Nevro. “Omnia's versatility means that patients now have access to a full range of SCS solutions and physicians can have the peace of mind that when they implant the system, they will have the capabilities needed to achieve the best possible outcomes for their patients.”

“Nevro pioneered the development of HF10 therapy, which has been highly effective in managing chronic pain in my practice, and the new Omnia system provides an even more advanced platform,” said Werner Braunsdorf, MD, Chief Physician of the Clinic for Neurosurgery and Spine Surgery at the Magdeburg Hospital (Germany). “HF10 therapy has proven to be very effective in many studies as well as in clinical practice, but I believe there have been some instances where it would have been beneficial to pair HF10 therapy with other waveforms or offer different waveforms independently. Omnia now provides me with that unmatched versatility.”

Related Links:
Nevro

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Steam Sterilizer
2000 RBE

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.